EATRIS, a Vision for Translational Research in Europe

被引:0
作者
Regina Becker
Guus A. M. S. van Dongen
机构
[1] Helmholtz Centre for Infection Research (HZI),EATRIS Project Management
[2] VU University Medical Center,Departments of Otolaryngology/Head and Neck Surgery and Nuclear Medicine and PET Research
来源
Journal of Cardiovascular Translational Research | 2011年 / 4卷
关键词
Translational research; Infrastructure; EATRIS; Translational centre; Molecular imaging; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
Tremendous progress has been made in biomedical research in genomics, proteomics and metabolomics, which has led to an increasing insight into molecular mechanisms related to diseases. Yet the output of disease prevention, diagnosis and treatment solutions remains low. It is against this background that several European countries have gathered to take new actions for improving translational research from bench to bedside. Surveys were conducted to identify major bottlenecks and assess the situation of translational research in Europe. While the importance of translational research is already recognized and national governments have increased their efforts and academia more and more directs its research towards translation, there are still hurdles to overcome. Thus, a European research infrastructure—EATRIS—will be established to integrate basic and clinical research in dedicated translational centres. These EATRIS Centres will provide broad access to high-end pre-clinical and clinical facilities, including the necessary translational expertise for researchers from academia and industry.
引用
收藏
页码:231 / 237
页数:6
相关论文
共 16 条
[1]  
Johnston SC(2006)Can industry rescue the National Institutes of Health? Annals of Neurology 60 A11-A14
[2]  
Hauser SL(2010)Driving drug discovery: The fundamental role of academic labs Science Translational Medicine 2 30cm16-2313
[3]  
Silber BM(2001)Obstacles facing translational research in academic medical centers The FASEB Journal 15 2303-743
[4]  
Pober JS(2010)Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine Nature Protocols 5 739-385
[5]  
Neuhauser CS(2010)Immuno-positron emission tomography: shedding light on clinical antibody therapy Cancer Biotherapy & Radiopharmaceuticals 25 375-201
[6]  
Pober JM(2010)Challenges with advanced therapy medicinal products and how to meet them Nature Reviews. Drug Discovery 9 195-undefined
[7]  
Vosjan MJWD(undefined)undefined undefined undefined undefined-undefined
[8]  
Perk LR(undefined)undefined undefined undefined undefined-undefined
[9]  
Visser GWM(undefined)undefined undefined undefined undefined-undefined
[10]  
Budde M(undefined)undefined undefined undefined undefined-undefined